Submitted to:

Ms.Bharti Godbole

Submitted By:
Anjali Bhatia (110205)

Mrityunjay Kumar (110221) Nancy Raheja (110222)

Priyanka Srivastava (110234) Shashank Kumar Vikrant Mishra (110240) (110250)

Industry:--Pharmaceutical Companys Name

1) 2)

Ranbaxy Laboratories Limited Sanofi-Aventis

Job Positions in Ranbaxy 1. Management trainee 2. Quality Assurance Manager

Job Positions in Sanofi-Aventis 1. Clinical Research Manager 2. Pharmacovigilance Manager

Industry scenario related to HR practices and challenges.

India Pharmaceutical
The Indian Pharmaceutical Industry today is in the front rank of Indias science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. It ranks very high in the third world, in terms of technology, quality and range of medicines manufactured. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously. Playing a key role in promoting and sustaining development in the vital field of medicines, Indian Pharma Industry boasts of quality producers and many units are approved by regulatory authorities in USA and UK. International companies associated with this sector have stimulated, assisted and spearheaded this dynamic development in the past 53 years and helped to put India on the pharmaceutical map of the world.

Growth Scenario in 2010

India's pharmaceutical industry is now the third largest in the world in terms of volume. Its rank is 14th in terms of value. Between September 2008 and September 2009, the total turnover of India's pharmaceuticals industry was US$ 21.04 billion. The domestic market was worth US$ 12.26 billion. This was reported by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. As per a report by IMS Health India, the Indian pharmaceutical market reached US$ 10.04 billion in size in July 2010. A highly organized sector, the Indian Pharma Industry is estimated to be worth $ 4.5 billion, growing at about 8 to 9 percent annually.

Top 10 Pharmaceutical Companies in India

1. Ranbaxy With a 2007 turnover of Rs 4,198.96 crore (Rs 41.989 billion) by sales, Ranbaxy is the largest pharmaceutical company in India.
2.

Dr Reddy's Laboratories With the turnover of Rs 4,162.25 crore (Rs 41.622 billion), Dr Reddy's Laboratories is the second largest pharmaceutical company in India.

3. Cipla With the revenue of Rs 3,763.72 crore (Rs 37.637 billion) Cipla is the third largest pharmaceutical company in India. 4. Sun Pharma Industries Sun Pharma Industries is the fourth largest pharma company in India with the total revenue of Rs 2,463.59 crore (Rs 24.635 billion) and led by Dilip Sanghvi.

5. Lupin Labs Lupin Labs has the total revenue of Rs 2,215.52 crore (Rs 22.155 billion 6. Aurobindo Pharma Sales revenues stood at Rs 2,080.19 crore (Rs 20.801 billion) makes it the sixth largest pharmaceutical company in India. 7. GlaxoSmithKline Pharma (GSK) GSK is the seventh largest pharma company with the total sales revenue of Rs 1,773.41 crore (Rs 17.734 billion) 8. Cadila Healthcare Eight largest company, has the total sale revenue at Rs 1,613.00 crore (Rs 16.13 billion) 9. Aventis Pharma Aventis Pharma has the revenue of Rs 983.80 crore (Rs 9.838 billion) and the ninth largest pharmaceutical company in India. 10. Ipca Laboratories With revenue of Rs 980.44 crore (Rs 9.804 billion), makes Ipca India's 10th largest pharma firm by sales.

Characteristics of Indian Pharmaceutical Industry

The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expanded drastically in the last two decades. The leading 250 pharmaceutical companies control 70% of the market with market leader holding nearly 7% of the market share. It is an extremely fragmented market with severe price competition and government price control. The pharmaceutical industry in India meets around 70% of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectibles. There are about 250 large units and about 8000 Small Scale Units, which form the core of the pharmaceutical industry in India (including 5 Central Public Sector Units). These units produce the complete range of pharmaceutical formulations, i.e., medicines ready for consumption by patients and about 350 bulk drugs, i.e., chemicals having therapeutic value and used for production of pharmaceutical formulations.

Following the de-licensing of the pharmaceutical industry, industrial licensing for most of the drugs and pharmaceutical products has been done away with. Manufacturers are free to produce any drug duly approved by the Drug Control Authority. Technologically strong and totally self-reliant, the pharmaceutical industry in India has low costs of production, low R&D costs, innovative scientific manpower, strength of national laboratories and an increasing balance of trade. The Pharmaceutical Industry, with its rich scientific talents and research capabilities, supported by Intellectual Property Protection regime is well set to take on the international market.

Future Prospects
The Indian pharmaceuticals market is expected to reach US$ 55 billion in 2020 from US$ 12.6 billion in 2009. This was stated in a report title "India Pharma 2020: Propelling access and acceptance, realizing true potential" by McKinsey & Company. In the same report, it was also mentioned that in an aggressive growth scenario, the pharma market has the further potential to reach US$ 70 billion by 2020 Due to increase in the population of high income group, there is every likelihood that they will open a potential US$ 8 billion market for multinational companies selling costly drugs by 2015. This was estimated in a report by Ernst & Young. The domestic pharma market is estimated to touch US$ 20 billion by 2015. The healthcare market in India is reported to reach US$ 31.59 billion by 2020. The sale of all types of pharmaceutical drugs and medicines in the country stands at US$ 9.61 billion, which is expected to reach around US$ 19.22 billion by 2012. Thus India would really become a lucrative destination for clinical trials for global giants. There was another report by RNCOS titled "Booming Pharma Sector in India" in which it was projected that the pharmaceutical formulations industry is expected to prosper in the same manner as the pharmaceutical industry. The domestic formulations market will grow at an annual rate of around 17% in 2010-11, owing to increasing middle class population and rapid urbanization.

Take two companies in the given sector and two jobs each- Analyze the jobs and list out the recruitment, selection training and development practices for these jobs.

RANBAXY LABORATORIES LIMITED

Company Profile Ranbaxy Laboratories Limited (Ranbaxy), India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The Company has a global footprint in 46 countries, world-class manufacturing facilities in 7 countries and serves customers in over 125 countries. Mission & Vision Ranbaxy's mission is To become a Research-based International Pharmaceutical Company. The Company is driven by its vision to Achieve significant business in proprietary prescription products by 2012 with a strong presence in developed markets. Financials Ranbaxy was incorporated in 1961 and went public in 1973. For the year 2009, the Company recorded Global Sales of US $ 1519 Mn. The Company has a balanced mix of revenues from emerging and developed markets that contribute 54% and 39% respectively. In 2009, North America, the Company's largest market contributed sales of US $ 397 Mn, followed by Europe garnering US $ 269 Mn and Asia clocking sales of around US $ 441 Mn. Strategy Ranbaxy is focused on increasing the momentum in the generics business in its key markets through organic and inorganic growth routes. Growth is well spread across geographies with focus on developed and emerging markets. It is the Companys constant endeavor to provide a wide basket of generic and innovator products, leveraging the unique Hybrid Business Model with Daiichi Sankyo. The Company will also increasingly focus in high growth potential segments like Vaccines and Biogenerics. These new areas will add significant depth to the existing product pipeline. R&D Ranbaxy views its R&D capabilities as a vital component of its business strategy that will provide a sustainable, long-term competitive advantage. The Company has a pool of over 1,200 R&D personnel engaged in path-breaking research. Ranbaxy is among the few Indian pharmaceutical companies in India to have started its research program in the late 70's, in support of its global ambitions. A first-of-its-kind world

class R&D centre was commissioned in 1994. Today, the Company has multi-disciplinary R&D centers at Gurgaon, in India, with dedicated facilities for generics research and innovative research. The R&D environment reflects its commitment to be a leader in the generics space offering value added formulations and development of NDA/ANDAs, based on its Novel Drug Delivery System (NDDS) research capability. Ranbaxys first significant international success using the NDDS technology platform came in September 1999, when the Company out-licensed its first once-a-day formulation to a multinational company. In July 2010, Ranbaxys New Drug Discovery Research (NDDR) was transferred to Daiichi Sankyo India Pharma Private Limited as part of the strategy to strengthen the global Research and Development structure of the Daiichi Sankyo Group. While NDDR will now become an integral part of Daiichi Sankyo Life Science Research Center in India, based in Gurgaon, Ranbaxy will continue to independently develop and later commercialise the anti-malarial new drug, Arterolane + PQP, which is currently in Phase III trials. Ranbaxy will also explore the further development of late stage programs developed by NDDR in the last few years, including the development programs in the GSK collaboration. Within Ranbaxy, R&D of Generics will now get a sharper focus, as the Company is increasingly working on more complex and specialist areas. HUMAN RESOURCE

Human Resource A career at Ranbaxy means an opportunity for ample learning & growth. It offers avenues to work across the globe alongside the finest minds. The Company offers a challenging assignment, a world class working environment, professional management, competitive salaries, stock options along with exceptional rewards. Opportunities The global spread of Ranbaxy and the blazing growth in business provides ample opportunities for our employees to build careers in various fields. Opportunities have never been a constraint for the deserving. They believe in employee growth that goes beyond vertical movements and change in designations. Potential and performance are the pillars of career progression at Ranbaxy. A robust development process supports this.

The managers generally have the opportunity to live and work in different countries; such international experience helps them better understand the complex business and grow both personally and professionally. Salary and Benefits Salaries and other benefits in Ranbaxy are comparable with the best in the industry and one can expect to be rewarded highly if the performance is consistently outstanding. Group Life Insurance, Medical Insurance and Pension plans are a few examples of the benefits provided to the employees and their dependents with adequate financial protection on long term basis. Employee Development Employees represent what a company stands for. The value an organization produces is unequivocally linked to collective efforts of its people. Ranbaxy realize that the growth of the company can be sustained through the continuous development of people who contribute to the business success. Hence they focus their attention to harness the innate potential each individual brings to the organization. JOB DESCRIPTION

FRESHER JOB PROFILE

Management trainee

Compensation:
Rs. 2, 00,000 - Rs. 2, 50,000

Education:
UG - B.Pharma Pharmacy, B.Sc Bio chemistry, Microbiology PG- M.sc. Bio Chemistry, Microbiology

Selection Process:
The resumes are scanned followed by GD/ PI. The selected candidates are given the offer letter and after the thorough medical check-up and background check-up, appointment letter are given to the candidates.

Training and development

The Management Trainee Programme In order to bring consistent growth, sustainability and novelty to the business operations they follow a special Management Trainee Programme. This programme aims at developing and nurturing young talents identified from premier Management Institutes of the country and trains them to excel in their respective area of specialization through on-job-trainings. Both behavioral and Functional trainings are imparted to them. They are put into diverse fields of businesses and challenging assignments which enables them to be fully prepared to tackle any business challenges of tomorrow thereby molding them to be our future leaders. Care has also been taken to provide them with ample opportunities for their personal and professional development. Management Trainees are provided with live projects which expose them to the various facets of business realities. They are not only under rotation in different fields of activities during their tenure but also work in Cross Functional Teams exposing them to deal with inter-related, complex and critical activities of business. Specific project assignments are also given under supervision and guidance of senior management members and periodic progress is monitored. They are also given inter-location trainings to get them familiarized with in-depth understanding of the functions at various stages of the business activity. Throughout the process, hand-holding and guidance of Global OD Function ensures all management Trainees make most out of their unique learning experience. After successful completion, a special evaluation committee constituted conducts merit driven evaluation of their results and performance under different projects. Based on their overall performance of the entire training period, they are regularized as Managers and accommodated into various departments of the organization. This unfolds the second phase of their journey of learning and achievements. JOB DESCRIPTION Quality Assurance Manager Designation Quality Assurance - Manager (R & D)

- The prime responsibility in this position would be to support R & D Job Description activities with quality assurance practices. - To co-ordinate for conducting self-inspection and/or quality audits of all quality function and procedures that regularly appraises the effectiveness and applicability of the Quality Assurance system. - Co-ordinate Technology Transfer activities - Handling of Quality Management System

- Harmonization of systems across all R & D centers -Implementation of all Standard Operating Procedure & ensure effectiveness - Ensure good development practices to be followed during product development Desired Profile -Post-graduate having experience in QA with reputed pharma company -Candidate must possess excellent communication & interpersonal skills - Hands on experience of Audit would be preferred Experience Industry Type Role 10 - 15 Years Pharma/ Biotech/Clinical Research QA/QC Mgr

Functional Area Production, Maintenance, Quality Education UG B.Pharma, PG - M.Pharma, B.Sc - Chemistry M.Sc - Chemistry

Training and development

After recruiting the candidates, the company provides 7 days in batch training. In this, training on different modules is given to the employees like on production and maintenance, quality control, quality assurance. At the end of each day, a question- answer session is undertaken whereby all the employees are asked questions related to what they have learnt in todays session. The main work of the person working at this position is to guide other employees.

Sanofi-Aventis
Sanofi-Aventis is a global healthcare leader. They offer a range of essential healthcare assets, including a broad-based product portfolio and a presence worldwide. At a glance 2010 sales: 30.384 million A broad portfolio of pharmaceutical products: prescription medicines, generics, consumer health care and animal health World leader in human vaccines A broad and balanced presence on both traditional and emerging markets About 102,000 employees in 100 countries Group strategy Ambition is to become a diversified global healthcare leader. Strategy is built around three priorities to reach its goals and ensure sustainable growth: Activities A range of dependable product offerings and a strategy adapted to local needs Sanofi-aventis can draw on a number of powerful assets to address the new context in the global pharmaceutical market: an extensive portfolio of prescription medicines, vaccines, generics medicines, consumer health care and animal health, along with a balanced presence on both traditional and emerging markets. Professional Development & Training Training is one of the essential components of People Development policy, both in terms of enabling the company to have the resources needed to respond to economic imperatives and to accompany employees professional and personal development Global Development programs Training is implemented by the different operational entities, at the most appropriate level. Global Development programs have also been designed to develop the corporate culture and support the groups strategy by offering managers opportunities for dialogue and personal development. Training activity within the Group Training activities make a strong contribution to our employees development, due to regular, sustained investment. During 2008, more than 86,000 people (84,000 in 2007) benefited from the Groups training actions. The number of hours devoted to training across the world

represents the equivalent of 40 hours training on average per employee trained Various position available Clinical Development Director Coordinator of international clinical studies Clinical Research Assistant Therapeutic Medical Advisor

JOB POSITION

Clinical Research Manager

Clinical Research Manager, Director of supplies, R&D Clinical Supply Chain The Clinical Research Manager sets up and follows clinical trials projects, ensures data quality and the respect of protocols and regulations.

Job Description A clinical research manager has to assume full responsibility for the preparing of protocols and CRF forms. He also has to be responsible for the overall activity of performing the clinical trial. He has to coordinate the monitoring of the trial and has to make sure that functioning is smooth by properly managing the staff. He has to establish audit procedures and ensure that data for the trial is being entered properly and accurately. He may have to participate in meetings of corporate research teams and ensure that his colleagues are aware of relevant issues. He has to develop systems for the tracking of projects, including all investigator, ethical review board information, study, financial management and patient recruitment activity. He has to train the sales representatives for product launches and cycle meetings. He also has to assume full responsibility for financially managing the clinical trial programme

including resource allocation, preparation of reports and budget planning. Eligibility Criteria Candidates with a bachelors degree in any of these subjects like life science, pharmacy, bioscience and medicine are eligible to apply for this job. However, preference is always given to candidates with two to three years of work experience. TRAINING AND DEVELOPMENT Off the job training Off the job training will bring expertise in clinical research and therapeutic area. After recruiting, the company provides 20 days of group training. Classroom training and presentations are given to the employees. The employees are sent to the research and development centre where the knowledge and skills of the employees are enhanced.

JOB POSITION Pharmacovigilance Manager

The Pharmacovigilance Manager establishes risk-evaluation and observation in the use of the products, before and during commercialization. They are in charge of evaluating the riskbenefit of a number of products in the Central Nervous System therapeutic area. They suggest risk-reducing measures and promote the appropriate use of the drug in order to guarantee patient safety. They manage the registration, follow-up and evaluation of product side-effects and guarantee the correct assessment of the risk-benefit ratio. They ensure effective communication on the tolerance of all global products of the Group to suppliers, healthcare authorities and subsidiaries. They write and update the standard operating procedures for the Pharmacovigilance department. Job Description Providing full service case management services Ensuring timely and accurate processing of individual reports and safety reporting to regulatory timelines. Educational background Physician or Pharmacist, with specialization in Pharmacovigilance.

TRAINING AND DEVELOPMENT Two days training program at the time of the joining of the job. In this program, presentations are shown through which knowledge about the medicines manufactured by the company and materials used are shown. There is also the information about the ingredients of the product. There is time to time training program conducted by the company for upgrading the knowledge of the employee about the new product of the company and the technologies used by the company.